Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

Immune-checkpoint blocking antibodies have demonstrated objective antitumor responses in multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). In melanoma, an increase in overall survival has been demonstrated with anti-CTLA-4 and PD-1 inhibition....

全面介紹

Na minha lista:
書目詳細資料
發表在:J Immunother Cancer
Main Authors: Heinzerling, Lucie, Ott, Patrick A., Hodi, F. Stephen, Husain, Aliya N., Tajmir-Riahi, Azadeh, Tawbi, Hussein, Pauschinger, Matthias, Gajewski, Thomas F., Lipson, Evan J., Luke, Jason J.
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
Short Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986340/
https://ncbi.nlm.nih.gov/pubmed/27532025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0152-y
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍